Home » Drug Is Voluntarily Withdrawn From UK Market
Drug Is Voluntarily Withdrawn From UK Market
Javelin Pharmaceuticals, a Cambridge developer of acute care pain products, said that a licensee of its Dyloject drug has announced that it is withdrawing all batches of Dyloject from the UK market to ensure patient safety.
boston
boston
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May